MedTrace Logo

Teduglutide in Short Bowel Syndrome Patients

NCT04857801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-04-26

No results posted yet for this study

Summary

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

Conditions

  • Short Bowel Syndrome

Interventions

DRUG

Teduglutide

effect of teduglutide on intestinal rehabilitation

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2020-06-01
Completion
2020-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04857801 on ClinicalTrials.gov